Alecensa (alectinib) - Roche
vebreltinib (APL-101) - Apollomics
Xalkori (crizotinib) - Pfizer
Tabrecta (capmatinib) - Novartis
Ensacove (ensartinib) - Betta Pharma
Lorbrena (lorlatinib) - Pfizer
Orpathys (savolitinib) - AstraZeneca, Hutchmed
https://cattendee.abstractsonline.com/meeting/21487/presentation/3139
 
Q-Q. Tan; J-j. Yan; H. Sun; H-J. Chen; Y-C. Zhang; K-J. Liu; J-J. Yang
 
Jul 31, 2026
 
Prev Next